484 related articles for article (PubMed ID: 16940064)
1. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
Bergman M; Huikko S; Huovinen P; Paakkari P; Seppälä H;
Antimicrob Agents Chemother; 2006 Nov; 50(11):3646-50. PubMed ID: 16940064
[TBL] [Abstract][Full Text] [Related]
2. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
[TBL] [Abstract][Full Text] [Related]
3. Distribution across the USA of macrolide resistance and macrolide resistance mechanisms among Streptococcus pneumoniae isolates collected from patients with respiratory tract infections: PROTEKT US 2001-2002.
Farrell DJ; Jenkins SG
J Antimicrob Chemother; 2004 Aug; 54 Suppl 1():i17-22. PubMed ID: 15265832
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibilities and distribution of resistance genes for beta-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo.
Noguchi N; Tano J; Nasu Y; Koyama M; Narui K; Kamishima H; Saito T; Tsuyuki K; Sasatsu M
Int J Antimicrob Agents; 2007 Jan; 29(1):26-33. PubMed ID: 17189091
[TBL] [Abstract][Full Text] [Related]
5. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
[TBL] [Abstract][Full Text] [Related]
6. Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.
Bergman M; Huikko S; Pihlajamäki M; Laippala P; Palva E; Huovinen P; Seppälä H;
Clin Infect Dis; 2004 May; 38(9):1251-6. PubMed ID: 15127336
[TBL] [Abstract][Full Text] [Related]
7. Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005.
Karlowsky JA; Lagacé-Wiens PR; Low DE; Zhanel GG
Int J Antimicrob Agents; 2009 Oct; 34(4):375-9. PubMed ID: 19560902
[TBL] [Abstract][Full Text] [Related]
8. [Streptococcus pneumoniae strains resistance to macrolide, lincosamide, streptogramin, oxazolidinone and ketolide].
Sener B; Köseoğlu O; Fişenk I; Hasçelik G; Günalp A
Mikrobiyol Bul; 2002 Apr; 36(2):125-31. PubMed ID: 12652863
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae.
Hiramatsu K; Ohama M; Mijajima Y; Kishi K; Mizunoe S; Tokimatsu I; Nagai H; Kadota J; Saikawa T; Nasu M
Int J Antimicrob Agents; 2004 Aug; 24(2):125-9. PubMed ID: 15288310
[TBL] [Abstract][Full Text] [Related]
10. Macrolide and ketolide resistance with Streptococcus pneumoniae.
Doern GV
Med Clin North Am; 2006 Nov; 90(6):1109-24. PubMed ID: 17116439
[TBL] [Abstract][Full Text] [Related]
11. Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic usage in Taiwan.
Hsueh PR
Clin Microbiol Infect; 2005 Nov; 11(11):925-7. PubMed ID: 16216110
[TBL] [Abstract][Full Text] [Related]
12. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of synergy of combinations of beta-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae.
Drago L; Nicola L; Rodighiero V; Larosa M; Mattina R; De Vecchi E
J Antimicrob Chemother; 2011 Apr; 66(4):845-9. PubMed ID: 21393187
[TBL] [Abstract][Full Text] [Related]
14. Penicillin and macrolide resistance in pneumococcal pneumonia: does in vitro resistance affect clinical outcomes?
Rothermel CD
Clin Infect Dis; 2004 May; 38 Suppl 4():S346-9. PubMed ID: 15127368
[TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
Schentag JJ; Klugman KP; Yu VL; Adelman MH; Wilton GJ; Chiou CC; Patel M; Lavin B; Paladino JA
Int J Antimicrob Agents; 2007 Sep; 30(3):264-9. PubMed ID: 17587549
[TBL] [Abstract][Full Text] [Related]
16. Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.
Hicks LA; Chien YW; Taylor TH; Haber M; Klugman KP;
Clin Infect Dis; 2011 Oct; 53(7):631-9. PubMed ID: 21890767
[TBL] [Abstract][Full Text] [Related]
17. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey.
Gulay Z; Ozbek OA; Bicmen M; Gur D
Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364
[TBL] [Abstract][Full Text] [Related]
18. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea.
Bae S; Lee K
Diagn Microbiol Infect Dis; 2009 Feb; 63(2):213-6. PubMed ID: 19097840
[TBL] [Abstract][Full Text] [Related]
19. The antimicrobial resistance profile of Streptococcus pneumoniae.
Reinert RR
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():7-11. PubMed ID: 19366363
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic consumption and link to resistance.
Goossens H
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():12-5. PubMed ID: 19366364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
